A detailed history of China Universal Asset Management Co., Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,752 shares of PTCT stock, worth $456,279. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,752
Previous 14,752 -0.0%
Holding current value
$456,279
Previous $429,000 -0.0%
% of portfolio
0.06%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$24.15 - $31.95 $145,503 - $192,498
6,025 Added 69.04%
14,752 $429,000
Q4 2023

May 21, 2024

SELL
$18.07 - $29.37 $108,871 - $176,954
-6,025 Reduced 40.84%
8,727 $240,000
Q4 2023

Jan 23, 2024

BUY
$18.07 - $29.37 $122,623 - $199,304
6,786 Added 349.61%
8,727 $241,000
Q3 2023

May 21, 2024

BUY
$22.41 - $41.99 $21,715 - $40,688
969 Added 99.69%
1,941 $43,000
Q3 2023

Oct 30, 2023

BUY
$22.41 - $41.99 $21,715 - $40,688
969 Added 99.69%
1,941 $43,000
Q2 2023

May 21, 2024

SELL
$40.4 - $59.1 $1,131 - $1,654
-28 Reduced 2.8%
972 $39,000
Q2 2023

Jul 27, 2023

SELL
$40.4 - $59.1 $1,131 - $1,654
-28 Reduced 2.8%
972 $40,000
Q1 2023

May 21, 2024

BUY
$38.16 - $48.86 $10,265 - $13,143
269 Added 36.8%
1,000 $48,000
Q1 2023

Apr 27, 2023

BUY
$38.16 - $48.86 $10,265 - $13,143
269 Added 36.8%
1,000 $48,000
Q4 2022

May 21, 2024

SELL
$33.53 - $54.79 $470,124 - $768,210
-14,021 Reduced 95.04%
731 $27,000
Q4 2022

Jan 31, 2023

BUY
$33.53 - $54.79 $2,045 - $3,342
61 Added 9.1%
731 $28,000
Q3 2022

Oct 21, 2022

BUY
$41.85 - $53.85 $28,039 - $36,079
670 New
670 $34,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.21B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.